NASDAQ:ICCC ImmuCell Corporation
First off don't take anything I say seriously or at face value, this is an opinion basis. As always, I could be wrong. That being said, let us get into the analysis. Doing a fibonacci-based analysis, I think a conservative medium risk target of $5.17 within the next upcoming weeks is feasible. I also think Immucell could have bullish retracement potential from its previous negative correlations last quarters. This means, it may be worth holding on to for a long position as well, but I would need to do more research before being personally confident. Definitely though, a stock on the watchlist. Giving calves immunity for E. coli, coronavirus and rotavirus, as they are hoping, would be high in demand right now. This is for obvious reasons. If there research goes somewhere, it is better to be safer then sorry with food resources. Especially if they get approved processes and end up being bioethically permissible.